As per the agreement, CCS’s highly flexible service becomes available for EMD Millipore’s well-proven assay cell lines, improving customers’ drug discovery and throughput functional screening capabilities. EMD Millipore
The manufacturing practices are believed to help in longer storage of medicines, The Hindu reported. The news agency quoted Lyka Labs saying to Bombay Stock Exchange that they
The company has raised $2.8m in the current share offering, with $1.3m in shares remaining to be sold, bizjournals.com reported. Heat Biologics is developing HIV vaccine besides other
In the latest financing round, Celator has raised $2.57m of its $5m target through equity, options and securities, medcitynews.com reported. The company’s investors include Quaker BioVentures, Ventures West,
Both the companies will take charge of developing new drug to treat and stopping the progression of dry Age-related Macular Degeneration (AMD), news.cens.com reported. The Phase II and
According to the company, the product featuring transdermal delivery technology reflects the company’s strength and capabilities. Fuse Science CIO and chief marketing officer Aitan Zacharin said until now
Proteonomix entered into a deal to conduct the clinical trial with the University of Miami, under which the University was required to pay expenses associated with the clinical
Both the companies entered into the drug discovery alliance in March 2009. It is believed that Zydus Cadila and Eli Lilly are faced with issues concerning differences in
Elsiglutide, a novel GLP-2 peptide agonist, is discovered by Zealand Pharma and licensed to Helsinn Healthcare, and is indicated in the treatment of diarrhea induced by chemotherapy in
Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) has been recommended as a single dose for use in adults who are 50 years old or more. According
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.